Tag: National Institutes of Health

RevBio secures NIH grant for game-changing TETRANITE Technology

businessnewstoday- October 7, 2023

RevBio, Inc., revealed that it has secured a substantial grant of up to $3.4 million, to be disbursed over the next three years, from the ... Read More

BITT secures NIH funding for pioneering Sjögren’s syndrome treatment

businessnewstoday- September 3, 2023

Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily receptor (TNFSR) antagonist antibodies, has received a ... Read More

US NIH stops ACTIV-2 phase 3 trial of Covid-19 drug candidate SAB-185

pallavi123- March 6, 2022

SAB Biotherapeutics said that the US National Institutes of Health (NIH) is discontinuing the phase 3 ACTIV-2 trial of the company’s SAB-185 for the treatment ... Read More

Bharat Biotech reports positive Covaxin phase 3 results with 77.8% efficacy

pallavi123- July 4, 2021

Covaxin phase 3 results : Bharat Biotech, an Indian biotech company, said that Covaxin, its whole virion inactivated vaccine against SARS-CoV2, has demonstrated efficacy of ... Read More

Sound Pharmaceuticals gets NIH grant for Covid-19 candidate SPI-1005

pallavi123- April 6, 2021

Sound Pharmaceuticals has secured a grant of $3.1 million for supporting the evaluation of its COVID-19 treatment candidate SPI-1005 in two phase 2 clinical trials ... Read More

Cancer Targeted Technology gets NIH grant to support CTT1403 trial

pharmanewsdaily- August 7, 2020

Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US National Institutes of Health (NIH) to support ... Read More

Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

pharmanewsdaily- May 19, 2020

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer ... Read More

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

pharmanewsdaily- March 17, 2020

Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the ... Read More